Article
Recent advance of next-generation sequencing in patients with lung cancer.
Expert review of molecular diagnostics - 1 Jan 2023
Qiu Tianyu, Zhi Xinxin, Ren Shengxiang
Abstract excerpt
INTRODUCTION: Precision medicine based on the driver genes mutation status is the current systemic therapeutic paradigm in patients with lung cancer. Next-generation sequencing (NGS) has emerged as a powerful platform for molecular diagnosis by virtue of high-throughput and massively parallel sequencing. Liquid biopsy also enabled the dynamic monitoring and comprehensive profiling of lung cancer in a noninvasive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
